KR101004205B1 - 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 - Google Patents
유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 Download PDFInfo
- Publication number
- KR101004205B1 KR101004205B1 KR1020080128499A KR20080128499A KR101004205B1 KR 101004205 B1 KR101004205 B1 KR 101004205B1 KR 1020080128499 A KR1020080128499 A KR 1020080128499A KR 20080128499 A KR20080128499 A KR 20080128499A KR 101004205 B1 KR101004205 B1 KR 101004205B1
- Authority
- KR
- South Korea
- Prior art keywords
- release
- udenafil
- controlled release
- acid
- release composition
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
Description
Claims (9)
- 유데나필 및 약학적으로 허용가능한 염;구연산, 말산, 아디프산, 말레인산, 아스코르빈산, 숙신산 또는 주석산의 유기산 중에서 선택되는 용해도 조절제;이산화규소, 규산칼슘, 탈크 및 알류미늄 마그네슘 메타실리케이트 중에서 선택되는 흡착제; 및히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시프로필메틸셀룰로오스, 폴리에틸렌옥사이드, 잔탄검, 구아검, 로커스트빈검 또는 알긴산나트륨 중에서 선택되는 친수성 폴리머를 포함하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 용해도 조절제는 구연산인 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 흡착제는 이산화규소인 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 친수성 폴리머는 히드록시프로필메틸셀룰로오스 또는 폴리에틸렌옥사이드 중에서 선택되는 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 공극형성제를 추가적으로 포함하는 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 팽창화제를 추가적으로 포함하는 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 희석제를 추가적으로 포함하는 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 제 1 항에 있어서, 활택제를 추가적으로 포함하는 것을 특징으로 하는 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물.
- 유데나필 및 약학적으로 허용가능한 염과 구연산, 말산, 아디프산, 말레인산, 아스코르빈산, 숙신산 또는 주석산의 유기산 중에서 선택되는 용해도 조절제가 혼합된 용액을 이산화규소, 규산칼슘, 탈크 및 알류미늄 마그네슘 메타실리케이트 중에서 선택되는 흡착제 표면에 흡착시켜 과립을 제조하는 단계; 및상기 제조된 흡착 과립을 히드록시에틸셀룰로오스, 히드록시프로필셀룰로오스, 히드록시프로필메틸셀룰로오스, 폴리에틸렌옥사이드, 잔탄검, 구아검, 로커스트빈검 또는 알긴산나트륨 중에서 선택되는 친수성 폴리머와 혼합하여 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물의 제조 방법.
Priority Applications (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080128499A KR101004205B1 (ko) | 2008-12-17 | 2008-12-17 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
RU2011129643/15A RU2480240C2 (ru) | 2008-12-17 | 2009-12-10 | Композиция с контролируемым высвобождением для производства препарата замедленного высвобождения, содержащего уденафил |
BRPI0923003A BRPI0923003A2 (pt) | 2008-12-17 | 2009-12-10 | composição de liberação controlada para produção de uma preparação de liberação prolongada contendo udenafil |
AU2009327758A AU2009327758A1 (en) | 2008-12-17 | 2009-12-10 | Controlled-release composition for producing sustained-release preparation containing udenafil |
PCT/KR2009/007382 WO2010071320A2 (ko) | 2008-12-17 | 2009-12-10 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
MX2011006450A MX2011006450A (es) | 2008-12-17 | 2009-12-10 | Composicion de liberacion controlada para producir una preparacion de liberacion sostenida que contiene udenafil. |
SG2011042561A SG172084A1 (en) | 2008-12-17 | 2009-12-10 | Controlled-release composition for producing sustained-release preparation containing udenafil |
MA33942A MA33022B1 (fr) | 2008-12-17 | 2009-12-10 | Composition à libération contrôlée pour produire une préparation à libération prolongée contenant de l'udénafil |
JP2011542002A JP2012512242A (ja) | 2008-12-17 | 2009-12-10 | ウデナフィル含有徐放性製剤を製造するための制御放出組成物 |
CA2746190A CA2746190A1 (en) | 2008-12-17 | 2009-12-10 | Controlled-release composition for producing sustained-release preparation containing udenafil |
US13/140,241 US20110250279A1 (en) | 2008-12-17 | 2009-12-10 | Controlled-release composition for producing sustained-release preparation containing udenafil |
EP09833598A EP2374479A4 (en) | 2008-12-17 | 2009-12-10 | CONTROLLED RELEASE COMPOSITION FOR PRODUCING LONG-TERM RELEASE PREPARATION CONTAINING UDEAFIL |
CN2009801562658A CN102307597A (zh) | 2008-12-17 | 2009-12-10 | 用于制备含乌地那非缓释制剂的控释组合物 |
ZA2011/04445A ZA201104445B (en) | 2008-12-17 | 2011-06-15 | Controlled-release composition for producing sustained-release preparation containing udenafil |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080128499A KR101004205B1 (ko) | 2008-12-17 | 2008-12-17 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100069939A KR20100069939A (ko) | 2010-06-25 |
KR101004205B1 true KR101004205B1 (ko) | 2010-12-24 |
Family
ID=42269213
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080128499A KR101004205B1 (ko) | 2008-12-17 | 2008-12-17 | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110250279A1 (ko) |
EP (1) | EP2374479A4 (ko) |
JP (1) | JP2012512242A (ko) |
KR (1) | KR101004205B1 (ko) |
CN (1) | CN102307597A (ko) |
AU (1) | AU2009327758A1 (ko) |
BR (1) | BRPI0923003A2 (ko) |
CA (1) | CA2746190A1 (ko) |
MA (1) | MA33022B1 (ko) |
MX (1) | MX2011006450A (ko) |
RU (1) | RU2480240C2 (ko) |
SG (1) | SG172084A1 (ko) |
WO (1) | WO2010071320A2 (ko) |
ZA (1) | ZA201104445B (ko) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102871997B (zh) * | 2011-07-12 | 2013-11-13 | 山东绿叶制药有限公司 | 含有去甲基文拉法辛苯甲酸酯类化合物的缓释药物组合物 |
KR102237799B1 (ko) | 2012-11-14 | 2021-04-08 | 더블유.알. 그레이스 앤드 캄파니-콘. | 생물학적 활성 물질 및 비-정렬된 무기 산화물을 함유하는 조성물 |
EP3082428A4 (en) | 2013-12-09 | 2017-08-02 | Respira Therapeutics, Inc. | Pde5 inhibitor powder formulations and methods relating thereto |
KR20170066334A (ko) | 2014-08-12 | 2017-06-14 | 주식회사 메지온 | 유데나필 조성물을 이용하여 폰탄 환자에서 심근 성능을 개선시키는 방법 |
WO2016168077A1 (en) * | 2015-04-16 | 2016-10-20 | Bpsi Holdings, Llc | Stabilized polyethylene oxide compositions |
KR102249155B1 (ko) * | 2019-07-26 | 2021-05-07 | 주식회사 코아팜바이오 | 유데나필을 함유하는 약제학적 조성물 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770295B1 (en) | 1998-08-27 | 2004-08-03 | Pharmacia Ab | Therapeutic formulation for administering tolterodine with controlled release |
US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
US20080220080A1 (en) | 2005-03-29 | 2008-09-11 | Röhm Gmbh | Multiparticulate Pharmaceutical form Comprising Pellets with a Substance Having a Modular Effect in Relation to Active Ingredient Release |
US20080292707A1 (en) | 2001-06-22 | 2008-11-27 | Pfizer Inc | Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0136527Y1 (ko) | 1993-11-30 | 1999-03-20 | 이대원 | 와이어 본딩 헤드 |
GB9523752D0 (en) * | 1995-11-21 | 1996-01-24 | Pfizer Ltd | Pharmaceutical formulations |
US6200604B1 (en) * | 1998-03-27 | 2001-03-13 | Cima Labs Inc. | Sublingual buccal effervescent |
ATE462417T1 (de) * | 1998-08-13 | 2010-04-15 | Cima Labs Inc | Microemulsionen als feste dosisformen zur oralen verabreichung |
UA67802C2 (uk) * | 1998-10-23 | 2004-07-15 | Пфайзер Рісьоч Енд Дівелепмент Компані, Н.В./С.А. | Фармацевтична композиція з контрольованим вивільненням інгібітора цгмф фде-5 (варіанти), спосіб її одержання та спосіб лікування еректильної дисфункції |
EP1171134A4 (en) * | 1999-03-16 | 2005-01-05 | Pentech Pharmaceuticals Inc | CONTROLLED DELIVERY OF SILDENAFIL ADMINISTERED BY SUBLINGUAL OR ORAL |
TW200400821A (en) | 1999-11-02 | 2004-01-16 | Pfizer | Pharmaceutical composition (II) useful for treating or preventing pulmonary hypertension in a patient |
AP2002002553A0 (en) | 1999-12-23 | 2002-06-30 | Pfizer Prod Inc | Hydrogel-driven Drug Dosoge Form. |
ATE444060T1 (de) * | 2001-06-22 | 2009-10-15 | Pfizer Prod Inc | Pharmazeutische zusammensetzungen enthaltend dispersionen aus arzneistoffen und neutralen polymeren |
KR200270330Y1 (ko) | 2001-10-09 | 2002-04-03 | 이대범 | 퍼머용 아이롱 |
DE102004027743A1 (de) | 2004-06-07 | 2006-01-05 | Fresenius Medical Care Deutschland Gmbh | Kappe, insbesondere Desinfektionskappe, Detektionsvorrichtung für die Peritonealdialyse, Beutelset für die Peritonealdialyse und dessen Verwendung |
CA2612917A1 (en) * | 2005-06-23 | 2007-01-04 | Schering Corporation | Rapidly absorbing oral formulations of pde5 inhibitors |
KR100912680B1 (ko) * | 2006-03-16 | 2009-08-19 | (주) 벡스코아 | 제어 방출 제형 |
KR100792126B1 (ko) | 2006-04-04 | 2008-01-04 | 동아제약주식회사 | 피라졸로피리미디논 화합물을 유효성분으로 함유하는전립선 비대증 예방 및 치료제 |
KR101304343B1 (ko) | 2006-04-06 | 2013-09-11 | 한미사이언스 주식회사 | Pde-5 억제제의 경구용 속용제형 |
KR100780479B1 (ko) * | 2006-05-08 | 2007-11-28 | 윈셋파마 주식회사 | 이부딜라스트 함유 경구용 제제 및 이의 제조방법 |
KR100791844B1 (ko) * | 2006-06-30 | 2008-01-07 | 주식회사유한양행 | 메트포르민 또는 그의 염을 함유하는 서방성 제제 및 그의제조방법 |
US20080014257A1 (en) * | 2006-07-14 | 2008-01-17 | Par Pharmaceutical, Inc. | Oral dosage forms |
KR200483492Y1 (ko) | 2015-03-31 | 2017-05-22 | 산제트 인터내셔널 컴퍼니, 리미티드 | 공작기계의 지능형 제어 시스템 |
-
2008
- 2008-12-17 KR KR1020080128499A patent/KR101004205B1/ko active IP Right Grant
-
2009
- 2009-12-10 AU AU2009327758A patent/AU2009327758A1/en not_active Abandoned
- 2009-12-10 MA MA33942A patent/MA33022B1/fr unknown
- 2009-12-10 CA CA2746190A patent/CA2746190A1/en not_active Abandoned
- 2009-12-10 RU RU2011129643/15A patent/RU2480240C2/ru not_active IP Right Cessation
- 2009-12-10 EP EP09833598A patent/EP2374479A4/en not_active Withdrawn
- 2009-12-10 US US13/140,241 patent/US20110250279A1/en not_active Abandoned
- 2009-12-10 SG SG2011042561A patent/SG172084A1/en unknown
- 2009-12-10 CN CN2009801562658A patent/CN102307597A/zh active Pending
- 2009-12-10 WO PCT/KR2009/007382 patent/WO2010071320A2/ko active Application Filing
- 2009-12-10 BR BRPI0923003A patent/BRPI0923003A2/pt not_active IP Right Cessation
- 2009-12-10 JP JP2011542002A patent/JP2012512242A/ja not_active Abandoned
- 2009-12-10 MX MX2011006450A patent/MX2011006450A/es not_active Application Discontinuation
-
2011
- 2011-06-15 ZA ZA2011/04445A patent/ZA201104445B/en unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770295B1 (en) | 1998-08-27 | 2004-08-03 | Pharmacia Ab | Therapeutic formulation for administering tolterodine with controlled release |
US20080292707A1 (en) | 2001-06-22 | 2008-11-27 | Pfizer Inc | Pharmaceutical Compositions of Adsorbates of Amorphous Drug |
US20050042177A1 (en) | 2003-07-23 | 2005-02-24 | Elan Pharma International Ltd. | Novel compositions of sildenafil free base |
US20080220080A1 (en) | 2005-03-29 | 2008-09-11 | Röhm Gmbh | Multiparticulate Pharmaceutical form Comprising Pellets with a Substance Having a Modular Effect in Relation to Active Ingredient Release |
Also Published As
Publication number | Publication date |
---|---|
RU2011129643A (ru) | 2013-01-27 |
EP2374479A4 (en) | 2012-09-12 |
EP2374479A2 (en) | 2011-10-12 |
RU2480240C2 (ru) | 2013-04-27 |
US20110250279A1 (en) | 2011-10-13 |
BRPI0923003A2 (pt) | 2015-12-15 |
KR20100069939A (ko) | 2010-06-25 |
WO2010071320A2 (ko) | 2010-06-24 |
WO2010071320A3 (ko) | 2010-09-30 |
AU2009327758A1 (en) | 2011-07-07 |
SG172084A1 (en) | 2011-07-28 |
ZA201104445B (en) | 2012-03-28 |
JP2012512242A (ja) | 2012-05-31 |
CN102307597A (zh) | 2012-01-04 |
CA2746190A1 (en) | 2010-06-24 |
MA33022B1 (fr) | 2012-02-01 |
MX2011006450A (es) | 2011-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101424843B1 (ko) | 의약 조성물 | |
DK2605757T3 (en) | Nalbuphine-based formulations and applications thereof | |
KR100780553B1 (ko) | 메트포르민 서방정 및 그의 제조방법 | |
KR101004205B1 (ko) | 유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물 | |
CZ2003211A3 (en) | Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates | |
KR20190049543A (ko) | 붕해가 개선된 경구용 고형 제제 조성물 및 이의 제조 방법 | |
EP3488845A1 (en) | Formulation having improved ph-dependent drug-release characteristics, containing esomeprazole or pharmaceutically acceptable salt thereof | |
CN109890372B (zh) | 含埃索美拉唑的复合胶囊及其制备方法 | |
JP2020535113A (ja) | エソメプラゾール、及びその薬学的に許容可能な塩を含むマルチユニット球状錠剤を含む薬剤学的組成物、並びにその製造方法 | |
KR20200082006A (ko) | 토파시티닙 또는 그의 약제학적으로 허용되는 염을 함유한 서방성 제제 및 그의 제조방법 | |
JP2017523149A (ja) | エドキサバンの医薬組成物 | |
CA2853117C (en) | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof | |
WO2020148219A1 (en) | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | |
JP2023071921A (ja) | 様々な用量のレナリドミドの経口用錠剤組成物 | |
EP3335702A1 (en) | Pharmaceutical compositions comprising omarigliptin | |
AU2020209883A1 (en) | A method of manufacturing a pharmaceutical composition comprising nefopam and acetaminophen, and the pharmaceutical composition obtained thereby | |
KR20210095583A (ko) | 프로톤 펌프 저해제 및 제산제를 포함하는 약제학적 복합제제 | |
JP2022541948A (ja) | エソメプラゾール及び炭酸水素ナトリウムを含む安定した薬学的組成物 | |
JP2008546830A (ja) | pH依存性の溶解度を有する有効成分の持続放出製剤 | |
RU2603469C2 (ru) | Таблетка с контролируемым высвобождением для перорального введения и способ ее приготовления | |
WO2011126327A2 (en) | Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof | |
KR20150088771A (ko) | 약제학적 복합제제 | |
KR20220000093A (ko) | 날트렉손 서방형 매트릭스 제제와 부프로피온 서방형 매트릭스 제제의 단층정 복합제제와 그 제조 방법 | |
KR101092257B1 (ko) | 안전역이 확보된 펠로디핀 제어방출형 제제 | |
AU2012233203A1 (en) | Solid preparation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20121231 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20131226 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20141211 Year of fee payment: 6 |
|
FPAY | Annual fee payment |
Payment date: 20151230 Year of fee payment: 7 |
|
FPAY | Annual fee payment |
Payment date: 20161222 Year of fee payment: 8 |
|
FPAY | Annual fee payment |
Payment date: 20171219 Year of fee payment: 9 |
|
FPAY | Annual fee payment |
Payment date: 20181217 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20191127 Year of fee payment: 11 |